CAHR extends its appreciation to all those that participated in the 33rd Canadian Conference on HIV/AIDS Research (CAHR 2024). The event took place in London, ON from April 25th to 28th, 2024 with over 600 participants coming together form across the country to share the latest scientific advances in the field, learn from one another’s expertise, and develop new ways to treat and prevent HIV.
CAHR thanks the dedicated work of the CAHR 2024 Scientific Planning Committee and the leadership of co-chairs Drs. Eric Arts and Carmen Logie.
CAHR also thanks its sponsors – in particular Gilead, ViiV and Merck — without whose generous contributions year in and year out, CAHR would not be able to host this great conference.
Conference Theme: Breaking Barriers, Building Bridges: Research to Action in HIV
Below is an overview of the Conference proceedings.
CAHR 2024 Sponsors
The Canadian Association for HIV Research (CAHR) gratefully acknowledges the companies and organizations which contribute to the Annual Canadian Conference on HIV/AIDS Research. These generous donations make it possible for CAHR to hold the national conference each year.